Search

Your search keyword '"ALLEGRO R"' showing total 188 results

Search Constraints

Start Over You searched for: Author "ALLEGRO R" Remove constraint Author: "ALLEGRO R"
188 results on '"ALLEGRO R"'

Search Results

3. The feasibility and prognostic value of sequential evaluation of EGFR cell expression in bladder washings after transurethral resection of Non-Muscle Invasive Bladder Cancer: A new potential tool to identify patients at higher risk of disease progression

7. Serenoa repens, lycopene and selenium vs tamsulosin in the treatment of LUTS/BPH: An Italian multicenter randomized comparative study between single or combination therapies (Procomb Study)

8. SERENOA REPENS, LICOPENE E SELENIUM VS. TAMSULOSINA PER IL TRATTAMENTO DEI LUTS: UNO STUDIO ITALIANO MULTICENTRICO RANDOMIZZATO COMPARATIVO TRA LA MONOTERAPIA O LA COMBINAZIONE (PROCOMB STUDY)

9. Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB Trial)

10. RISULTATI DI UNO STUDIO RANDOMIZZATO SULLA TOSSICITÀ E SUL RUOLO DEL MANTENIMENTO NELLA CHEMIOPROFILASSI ENDOVESCICALE PRECOCE DOPO TUR DI CARCINOMA VESCICALE SUPERFICIALE

11. Living Conditions in the Historical Center of Palermo

12. Attività lavorativa e fattori di rischio ambientale in pazienti affetti da carcinoma vescicale superficiale

22. FUMO DI SIGARETTA E RISORSA IDRICA IN PAZIENTI AFFETTI DA CARCINOMA VESCICALE SUPERFICIALE

25. 774 Serenoa repens, lycopene and selenium vs tamsulosin in the treatment of LUTS/BPH: An Italian multicenter randomized comparative study between single or combination therapies (Procomb Study)

28. 1041 MONTHLY MAINTENANCE AFTER EARLY INTRAVESICAL CHEMOTHERAPY

31. Results at 48 Months of a Randomized Trial on Maintenance after Early Adjuvant

34. A RANDOMISED STUDY EVALUATING MAINTENANCE SCHEDULE IN EARLY ADJUVANT CHEMOTHERAPY FOR INTERMEDIATE RISK NON-MUSCLE-INVASIVE BLADDER CANCER

41. 871Water chlorination and other environmental factors in bladder cancer. Result of a multicentre study

45. Trattamento conservativo e sopravvivenza in pazienti affetti da urotelioma vescicale T1G3. Quando proporlo e quando la cistectomia?

46. Risultati a 48 mesi di uno studio randomizzato sull'efficacia del mantenimento dopo chemioterapia endovescicale con inizio precoce in pazienti affetti da uroteliomi a rischio intermedio.

47. Osservational Study on Early Diagnosis of Prostate Carcinoma in Sicily and Calabria

48. Environmental Risk Factors in Superficial Bladder Cancer

49. Uroteliomi vescicali a basso rischio: quanto affidabili sono le EORTC Risk Tables?

Catalog

Books, media, physical & digital resources